 Generation Bio Co NASDAQ: GBIO provided an update on factor VIII expression from a series of mouse and companion non-human primate NHP studies in hemophilia A and an update on its development non-viral genetic medicine platform. In mouse studies, rapid enzymatic synthesis RES-derived ceDNA delivered by ctLNP generated peak mean human factor VIII expression of 205 of normal at 2.0 mgkg. 